Compare Raymond James Financial, Inc. (RJF) vs Viatris Inc (VTRS) Price & Performance

Raymond James Financial (RJF) trades at $158.6, up 0.83% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company has delivered three consecutive quarterly earnings beats, with Q3 2026 EPS of $3.14 exceeding the $2.93 estimate. Revenue growth has been steady, rising from $10.9B in 2022 to $13.84B in 2025, supported by a robust net income margin of 15.37% and an ROE of 18.48%.

The outlook is balanced: analyst consensus is a 'Hold' with a $184 price target, implying 16% upside, but technical weakness and volatile cash flows from aggressive investing activities pose near-term risks. Long-term growth drivers include wealth management expansion and investment banking recovery, though rising expenses and market volatility remain headwinds.

Viatris (VTRS) trades at $17.44, down 0.29% on the day, with a bullish technical outlook supported by moving averages and oversold RSI levels. The company has beaten earnings estimates for three consecutive quarters, though it faces profitability challenges with negative net margins. Recent positive developments include FDA approval for WAKIX in Japan and consistent dividend payments, while analyst consensus leans toward a buy rating with a $22.17 price target representing 27% upside potential.

The stock presents a value opportunity with reasonable P/S and P/B ratios, but investors must weigh strong cash generation against persistent profitability issues. Key catalysts include continued earnings beats and pipeline progress, while risks involve margin pressure and high debt levels. The current valuation disconnect between technical strength and fundamental challenges creates a balanced risk-reward profile for patient investors.